Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125977802 | 12597780 | 2 | F | 20160805 | 20160727 | 20160818 | EXP | JP-MYLANLABS-2016M1030005 | MYLAN | FUNAKOSHI R.. PRE-AVOID PLAZA: PHARMACEUTICAL CARE BY DOSE REDUCTION IN ELDERLY WITH MULTIPLE DISEASES AND MULTIPLE PRESCRIPTIONS.. JOURNAL OF JAPANESE SOCIETY OF HOSPITAL PHARMACISTS. 2016;52(7):874-876 | 0.00 | Y | 0.00000 | 20160818 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125977802 | 12597780 | 1 | PS | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 990 MG, QD | Y | U | 0 | 990 | MG | TABLET | QD | ||||
| 125977802 | 12597780 | 2 | SS | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | FREQUENCY OF AS NEEDED | Y | U | 0 | TABLET | |||||||
| 125977802 | 12597780 | 3 | SS | DISTIGMINE BROMIDE | DISTIGMINE BROMIDE | 1 | Oral | 5 MG, QD | Y | U | 0 | 5 | MG | TABLET | QD | ||||
| 125977802 | 12597780 | 4 | SS | PAZOPANIB | PAZOPANIB | 1 | Oral | 400 MG, QD | U | U | 0 | 400 | MG | TABLET | QD | ||||
| 125977802 | 12597780 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 125977802 | 12597780 | 6 | C | ETODOLAC. | ETODOLAC | 1 | Oral | 400 MG, QD | 0 | 400 | MG | TABLET | QD | ||||||
| 125977802 | 12597780 | 7 | C | CILOSTAZOL. | CILOSTAZOL | 1 | Oral | 200 MG, QD | 0 | 200 | MG | TABLET | QD | ||||||
| 125977802 | 12597780 | 8 | C | VALSARTAN. | VALSARTAN | 1 | Oral | 40 MG, QD | 0 | 40 | MG | TABLET | QD | ||||||
| 125977802 | 12597780 | 9 | C | MECOBALAMIN | METHYLCOBALAMIN | 1 | Oral | 1000 ?G, QD | 0 | 1000 | UG | TABLET | QD | ||||||
| 125977802 | 12597780 | 10 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0.2 MG, QD | 0 | .2 | MG | TABLET | QD | ||||||
| 125977802 | 12597780 | 11 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125977802 | 12597780 | 1 | Product used for unknown indication |
| 125977802 | 12597780 | 3 | Product used for unknown indication |
| 125977802 | 12597780 | 4 | Renal cancer |
| 125977802 | 12597780 | 5 | Hypertension |
| 125977802 | 12597780 | 6 | Osteoarthritis |
| 125977802 | 12597780 | 7 | Cerebral infarction |
| 125977802 | 12597780 | 8 | Hypertension |
| 125977802 | 12597780 | 9 | Neuropathy peripheral |
| 125977802 | 12597780 | 10 | Benign prostatic hyperplasia |
| 125977802 | 12597780 | 11 | Chronic gastritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125977802 | 12597780 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125977802 | 12597780 | Cholinergic syndrome | |
| 125977802 | 12597780 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125977802 | 12597780 | 1 | 20150708 | 0 | ||
| 125977802 | 12597780 | 2 | 20150710 | 0 | ||
| 125977802 | 12597780 | 3 | 20150618 | 0 | ||
| 125977802 | 12597780 | 4 | 20150707 | 0 | ||
| 125977802 | 12597780 | 5 | 201409 | 0 | ||
| 125977802 | 12597780 | 6 | 201409 | 0 | ||
| 125977802 | 12597780 | 7 | 201307 | 0 | ||
| 125977802 | 12597780 | 8 | 201412 | 0 | ||
| 125977802 | 12597780 | 9 | 201409 | 0 | ||
| 125977802 | 12597780 | 10 | 20150608 | 0 | ||
| 125977802 | 12597780 | 11 | 20150708 | 0 |